MedTrace Logo

Associating Renal Transplantation With the ITN Signature of Tolerance

NCT01516177 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2016-12-20

No results posted yet for this study

Summary

This is an observational study for people who have received a kidney transplant within the past 1 to 5 years. Researchers in this study are looking for a certain pattern of genes and cells in the blood that has been found in a group of rare transplant patients who do not need immunosuppression. The study goal is to find out how common this pattern is in transplant patients, as a first step in determining if it can be used to personalize anti-rejection drug regimens better.

Conditions

  • Kidney Transplantation

Sponsors & Collaborators

  • Immune Tolerance Network (ITN)

    collaborator NETWORK

  • Clinical Trials in Organ Transplantation

    collaborator NETWORK

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • Anil Chandraker, MD · Brigham and Women's Hospital

  • Kenneth Newell, MD, PhD · Emory University

  • Laurence Turka, MD · Beth Israel Deaconess Medical Center

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2014-04-30
Completion
2014-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01516177 on ClinicalTrials.gov